← Portfolio Scout

Portfolio company

Rapidemic

Country not known yet

Raised

Not known yet

Latest stage

Not known yet

Rounds recorded

Not known yet

Backed by

1 investor

Sectors

Deep TechDigital Health

About

Rapidemic develops molecular point-of-care diagnostic tests for sexually transmitted infections, providing results for patients and clinicians without requiring laboratory infrastructure or external power.

Source

Funding history · 0

No rounds recorded yet. The agent looks for them over time.

Similar companies